A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Overview of attention for article published in BMC Psychiatry, July 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source
twitter: 8 X users

patent: 2 patents
facebook: 1 Facebook page
googleplus: 1 Google+ user

Readers on

mendeley: 229 Mendeley

Summary Blogs Policy documents X Patents Facebook Google+

So far, Altmetric has seen 2 policy documents that reference this research output.

Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie: Evidenzbericht

Cited by The Association of the Scientific Medical Societies in Germany on 24 Mar 2021

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie: Langfassung der Leitlinie "Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter. Teil 2: Therapie"